Loading...
BVMF
HAPV3
Market cap934mUSD
Jul 09, Last price  
10.07BRL
1D
1.10%
1Q
-24.00%
IPO
-87.94%
Name

Hapvida Participacoes e Investimentos SA

Chart & Performance

D1W1MN
BVMF:HAPV3 chart
P/E
P/S
0.15
EPS
Div Yield, %
Shrs. gr., 5y
15.17%
Rev. gr., 5y
29.85%
Revenues
31.58b
+9.21%
1,963,568,0002,459,008,0003,036,454,0003,847,981,0004,575,898,0005,634,383,0008,554,961,0009,883,385,00023,748,803,00027,949,573,00028,914,698,00031,577,240,000
Net income
-142m
L-78.17%
270,091,000301,238,000457,120,000648,768,000787,470,000849,825,000783,464,000497,795,000-777,234,000-615,151,000-649,301,000-141,747,000
CFO
324m
-88.04%
334,209,000356,868,000483,651,000618,548,000516,696,000656,779,0001,325,635,000251,504,000971,907,0002,317,970,0002,711,352,000324,323,000
Dividend
Dec 28, 20210.0295 BRL/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hapvida Participações e Investimentos S.A., operating alongside its affiliated companies, is a key player in the Brazilian healthcare sector. The organization provides a variety of health and dental insurance plans. Its service offerings extend to direct medical and paramedical care, complemented by a suite of diagnostic services such as laboratory analysis, imaging, and ultrasound. Additionally, Hapvida supports educational initiatives by organizing courses, lectures, seminars, and similar events. The company is also involved in the administration, consultancy, deployment, and sale of individual, family, and collective healthcare systems and plans. It manages the reimbursement of medical, dental, hospital, and general healthcare expenses for its members, while simultaneously offering direct medical and hospital services. Hapvida maintains an extensive operational infrastructure, comprising 85 hospitals, 77 emergency units, 318 clinics, and 269 diagnostic centers. The company was founded in 1979 and is headquartered in Fortaleza, Brazil.
IPO date
Apr 25, 2018
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT